Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 89 publications
A Telemedicine-Supported Home-Injection Model for Patients With Breast Cancer.
Journal: JAMA network open
Published: August 21, 2026
Feasibility Study: Early Experiences With a Cancer Center's Virtual Expert Medical Opinion Program.
Journal: JCO oncology practice
Published: April 09, 2026
Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 26, 2026
Sustained benefit of adjuvant olaparib in women with germline BRCA1- and BRCA2- -associated high-risk HER2-negative early breast cancer: Updated results from the OlympiA phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 25, 2026
First-line treatment patterns and real-world survival outcomes in PD-L1-negative locally recurrent inoperable or metastatic triple-negative breast cancer in the United States.
Journal: Breast cancer research and treatment
Published: February 24, 2026
Correction: Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer.
Journal: Breast cancer research and treatment
Published: February 18, 2026
Real-World Treatment Patterns and Outcomes for Patients With Metastatic Triple-Negative Breast Cancer in the United States: An Observational Study.
Journal: JCO oncology practice
Published: January 07, 2026
Ambient Artificial Intelligence Scribes in Oncology: Adoption, Feasibility, Acceptability, and Appropriateness.
Journal: Applied clinical informatics
Published: September 03, 2025
Palbociclib with adjuvant endocrine therapy in early breast cancer: 5-year follow-up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: August 27, 2025
Prognostic value of visually and computationally assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030).
Journal: Journal of the National Cancer Institute
Published: June 30, 2025
Datopotamab deruxtecan-associated select adverse events: clinical practices and institutional protocols on prophylaxis, monitoring, and management.
Journal: The oncologist
Published: January 02, 2025
Optimizing Postneoadjuvant Treatment of Residual Breast Cancer With Adjuvant Bevacizumab Alone, With Metronomic or Standard-Dose Chemotherapy: A Combined Analysis of DFCI 05-055 and DFCI 09-134/TBCRC 012/ABCDE Clinical Trials.
Journal: Clinical breast cancer
Published: October 31, 2024
Last Updated: 09/26/2026